Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on July 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

IR System Add-ons (Microplastics)

Closed
NOI-FDA-134639Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The U.S. Food and Drug Administration is procuring a counter-propagating mode upgrade for its existing Photothermal mIRageLS microscope under a sole-source, non-competitive acquisition, justified by the exclusive ownership of Optical Photothermal Infrared (O-PTIR) technology by Photothermal Spectroscopy Corp. (PSC), the only entity capable of delivering full system compatibility with the FDA’s current instrumentation. This upgrade, intended for the detection of microplastics and nanoplastics in human foods, requires seamless integration into the existing software platform and must enable electronic switching between co- and counter-propagating imaging modes with sub-500 nm spatial resolution, a capability uniquely provided by PSC through its patented technologies. The acquisition is constrained to PSC due to its exclusive patent portfolio, manufacturer-specific authorization requirements for installation and qualification, and the impossibility of achieving technical functionality with any other vendor. As a registered small business with CAGE code 83PQ8 and NAICS code 334516, PSC is the sole responsible source, and the procurement is structured as a Firm-Fixed-Price purchase order under simplified acquisition procedures, valued between $25,001 and $250,000. Performance is to occur at the FDA’s facility in College Park, Maryland, with acceptance criteria centered on functional integration, software compatibility, and manufacturer-authorized commissioning. No competition is permitted or practicable, and all responders must demonstrate formal authorization from PSC to distribute and service the O-PTIR system, alongside proof of small business status and prior contract performance. The presolicitation was issued on July 30, 2026, with a deadline for capability statements on August 13, 2026, and an anticipated award date no later than September 9, 2026. Communication and submissions are handled exclusively via email to designated FDA contracting personnel, with no formal contract clauses, detailed pricing, or logistical specifications provided at this stage.

General Info

FDA sole-source contract to Photothermal Spectroscopy Corp. for O-PTIR microplastics add-on, compatible with existing system, due to exclusive patents.

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance

College Park, MD, 20740, USA

Set-Aside

NONE

Documents

1

PreSolicitation Notice FDA-134639 IR System Add-ons (Microplastics)

PDF, High priority: read this firstpresolicitation
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts2 people available
OfficeRockville, MD, 20852, USA
Office AddressRockville, MD, 20852, USA
Contacts
Aarati Singal
Sarah Hussain

Full Description

Show more

Pursuant to RFO 5.101(c)(4)(vii), the following identifies the intended source and explains why competition is not practicable for this requirement. 


Intended Contractor: 


Photothermal Spectroscopy Corp. 


325 Chapala St Santa Barbara, CA 93101 


CAGE Code: 83PQ8 



The basis for limiting this solicitation to a single source is that only one source is reasonably available, consistent with RFO 13.101(b) and the single-source standard at RFO 12.201-1(c).


Photothermal Spectroscopy Corp “PSC” is the one and only supplier that can meet the performance requirements outlined in the Statement of Work. The counter-propagating mode upgrade must be 100% compatible with the existing Photothermal mIRageLS to provide a seamless integration and establish full system communication and control through the single, existing software currently at FDA. PSC owns the patent for intellectual property protecting the O-PTIR technology and its associated capabilities. O-PTIR is protected by multiple patents and is exclusively available from Photothermal Spectroscopy. PSC will be the only provider to support the FDA in this requirement of the necessary parts and knowledgeable installation team to ensure 100% compatibility of the upgrade with the current FDA instrument. Photothermal is a US company and is a registered small business. A Brand Name acquisition is recommended, since only one provider meets the requirements for the acquisition.  


A written single-source justification has been prepared and approved in accordance with RFO 12.201-1(c) and RFO 13.101(b).

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541611
New
Federal
Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
Solicitation # 75F40126R00009
Solicitation 75F40126R00009 is a request for proposals for a single Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide Contractor-Hosted Fully Integrated Records Facility (FIRF) services for the FDA. This acquisition is exclusively set aside for Service-Disabled Veteran-Owned Small Business (SDVOSB) concerns under NAICS code 541611. The contract has a maximum ceiling of 50 million dollars with a guaranteed minimum of 10,000 dollars. The anticipated period of performance consists of five 12-month ordering periods from December 1, 2026, through November 30, 2031, with an additional six-month option to extend services through May 31, 2032. The contract will support various task order types, including Time-and-Materials, Labor-Hour, and Firm-Fixed Price. The scope of work requires the contractor to manage an offsite document control facility to standardize records management and transition the agency toward a near 100 percent electronic environment for premarket and postmarket submissions. Key task areas include program management, document processing, scanning, data entry, tracking, temporary storage, and transition activities. Performance will primarily occur at FDA facilities in the Washington, D.C. metropolitan area, specifically within Maryland. Award will be made on a Lowest Price-Technically Acceptable (LPTA) basis, evaluating technical factors and past performance on an acceptable or unacceptable basis. Proposals must be submitted electronically in three separate volumes, with a final submission deadline of November 5, 2026, at 2:00 PM Eastern Time.
Administrative Management and General Management Consulting Services

POSTED

2 days ago

DEADLINE

in 7 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS